Official websites use .gov
Secure .gov websites use HTTPS
Titles
- Size, shape, and other physical attributes of generic tablets and capsules: guidance for industry1
- Slowly progressive, low-prevalence rare diseases with substrate deposition that result from single enzyme defects: providing evidence of effectiveness for replacement or corrective therapies1
- Smallpox (variola virus) infection: developing drugs for treatment or prevention1
- Smoking cessation and related indications: developing nicotine replacement therapy drug products : guidance for industry1
- Social Security Administration: Actions needed by SSA to ensure disability medical consultants are properly screened and trained : report to the Committee on Ways and Means, Subcommittee on Social Security, House of Representatives1
- Social Security disability insurance: information on potential implications of expanding private disability insurance : report to Congressional requesters1
- Social Security disability: action needed to help agency staff understand and follow policies related to prescription opioid misuse : report to the Subcommittee on Social Security, Committee on Ways and Means, House of Representatives1
- Social Security disability: additional measures and evaluation needed to enhance accuracy and consistency of hearings decisions : report to the Chairman, Subcommittee on Social Security, Committee on Ways and Means, House of Representatives1
- Social Security disability: better timeliness metrics needed to assess transfers of appeals work : report to Congressional requesters1
- Social Security replacement rates and other benefit measures: an in-depth analysis1
- Social Security's finances: testimony before the Subcommittee on Social Security, Committee on Ways and Means, U.S. House of Representatives1
- Social needs screening among non-federal acute care hospitals, 20221
- Soft (hydrophilic) daily wear contact lenses: performance criteria for safety and performance based pathway : guidance for industry and Food and Drug Administration staff1
- Software as a medical device (SAMD): clinical evaluation : guidance for industry and Food and Drug Administration staff1
- Some Medicare Advantage Organization denials of prior authorization requests raise concerns about beneficiary access to medically necessary care1
- Some Medicare Advantage companies leveraged chart reviews and health risk assessments to disproportionately drive payments1
- Some Medicare Part D beneficiaries face avoidable extra steps that can delay or prevent access to prescribed drugs1
- Some account of the State prison or penitentiary house, in the city of New-York1
- Some manufacturers reported inaccurate drug product data to CMS1
- Some nursing homes' reported staffing levels in 2018 raise concerns: consumer transparency could be increased1